Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-004460
Filing Date
2025-02-18
Accepted
2025-02-18 17:00:17
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 form4-02182025_050212.html 4  
1 form4-02182025_050212.xml 4 14708
  Complete submission text file 0001415889-25-004460.txt   16090
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
SALEKI-GERHARDT AZITA (Reporting) CIK: 0001563545 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35565 | Film No.: 25635954